{"id":44967,"date":"2012-05-17T12:19:56","date_gmt":"2012-05-17T12:19:56","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/premier-issue-of-bioresearch-open-access-launched-by-mary-ann-liebert-inc-publishers.php"},"modified":"2012-05-17T12:19:56","modified_gmt":"2012-05-17T12:19:56","slug":"premier-issue-of-bioresearch-open-access-launched-by-mary-ann-liebert-inc-publishers","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-engineering\/premier-issue-of-bioresearch-open-access-launched-by-mary-ann-liebert-inc-publishers.php","title":{"rendered":"Premier issue of BioResearch Open Access launched by Mary Ann Liebert Inc. publishers"},"content":{"rendered":"<p><p>Public  release date: 16-May-2012  [ |   E-mail   |  Share    ]  <\/p>\n<p>    Contact: Cathia Falvey    <a href=\"mailto:cfalvey@liebertpub.com\">cfalvey@liebertpub.com<\/a>    914-740-2100    Mary    Ann Liebert, Inc.\/Genetic Engineering News<\/p>\n<p>    New Rochelle, NY, May 16, 2012The inaugural issue of    BioResearch Open Access, a new bimonthly peer-reviewed    open access journal, was released today by Mary Ann Liebert,    Inc., publishers. The Journal provides a new rapid-publication    forum for a broad range of scientific topics including but not    limited to molecular and cellular biology, tissue engineering    and biomaterials, regenerative medicine, stem cells, gene    therapy, systems biology, genetics, biochemistry, virology,    microbiology, and neuroscience. The first issue is available on    the BioResearch Open Access website at <a href=\"http:\/\/www.liebertpub.com\/biores\" rel=\"nofollow\">http:\/\/www.liebertpub.com\/biores<\/a>.  <\/p>\n<p>    The premier issue includes research papers and a brief report    from the U.S., U.K., Germany, and Korea on diverse topics such    as tissue engineering, stem cells, HIV, and genetics.    Forthcoming papers for the second issue include genetics,    xenotransplantation, nuclear transfer, and cardiac research.  <\/p>\n<p>    The Journal is under the leadership of Editor-in-Chief Jane    Taylor, PhD, Senior Research Fellow, MRC Centre for    Regenerative Medicine, University of Edinburgh, and seasoned    journal editors as Section Editors, including James M. Wilson,    MD, PhD, University of Pennsylvania; Antonios G. Mikos, PhD,    Rice University; Professor Sir Ian Wilmut, OBE FRS FRSE,    University of Edinburgh; Peter C. Johnson, MD, Scintellix, LLC,    Raleigh, NC; Aubrey D.N.J. de Grey, PhD, SENS Foundation,    Cambridge, UK; Alan J. Russell, PhD, Carnegie Mellon    University; Thomas Hope, PhD, Northwestern University; Ganes C.    Sen, PhD, Cleveland Clinic Foundation; Bruce A. Sullenger, PhD,    Duke University Medical Center; Graham C. Parker, PhD, Wayne    State University School of Medicine; Carol Shoshkes Reiss, PhD,    New York University; Stephen C. Ekker, PhD, Mayo Clinic,    Rochester, MN; John B. West, MD, PhD, University of California,    San Diego; David L. Woodland, PhD, Chief Scientific Officer,    Keystone Symposia on Molecular and Cellular Biology; Stephen    Higgs, PhD, Kansas State University; Eugene Kolker, PhD,    Seattle Children's Hospital; and Domenico Grasso, PhD, PE, DEE,    University of Vermont.  <\/p>\n<p>    The Journal welcomes basic science and translational research    in the form of original research articles, comprehensive review    articles, mini-reviews, rapid communications, brief reports,    technical reports, hypothesis articles, perspectives, and    letters to the editor. All articles in BioResearch Open    Access will be published online within 4 weeks of    acceptance. Articles will be fully open access and posted on    PubMedCentral. All articles submitted through July 15, 2012    will be made open access without article processing charges.    BioResearch Open Access is fully NIH-, HHMI-, and    Wellcome Trust compliant.  <\/p>\n<p>    \"BioResearch Open Access is a fully refereed    multidisciplinary journal and provides all the checks and    balances that rigorous peer review ensures,\" says Mary Ann    Liebert, president of Mary Ann Liebert, Inc., publishers. \"An    outstanding editorial team comprised of experienced journal    editors guarantees the integrity of the Journal.\"  <\/p>\n<p>    ###  <\/p>\n<p>    About the Publisher  <\/p>\n<p>    Mary Ann Liebert, Inc., publishers is a privately held, fully    integrated media company known for establishing authoritative    peer-reviewed journals in many promising areas of science and    biomedical research, including Tissue Engineering,    Human Gene Therapy, Nucleic Acid Therapeutics,    Stem Cells and Development, Viral Immunology,    DNA and Cell Biology, and Antioxidants & Redox    Signaling. Its biotechnology trade magazine, Genetic    Engineering & Biotechnology News (GEN), was the first in    its field and is today the industry's most widely read    publication worldwide. A complete list of the firm's 70    journals, books, and newsmagazines is available on the Mary Ann    Liebert, Inc. website at <a href=\"http:\/\/www.liebertpub.com\" rel=\"nofollow\">http:\/\/www.liebertpub.com<\/a>.  <\/p>\n<\/p>\n<p>Read more:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.eurekalert.org\/pub_releases\/2012-05\/mali-pio051612.php\" title=\"Premier issue of BioResearch Open Access launched by Mary Ann Liebert Inc. publishers\">Premier issue of BioResearch Open Access launched by Mary Ann Liebert Inc. publishers<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Public release date: 16-May-2012 [ | E-mail | Share ] Contact: Cathia Falvey <a href=\"mailto:cfalvey@liebertpub.com\">cfalvey@liebertpub.com<\/a> 914-740-2100 Mary Ann Liebert, Inc.\/Genetic Engineering News New Rochelle, NY, May 16, 2012The inaugural issue of BioResearch Open Access, a new bimonthly peer-reviewed open access journal, was released today by Mary Ann Liebert, Inc., publishers.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-engineering\/premier-issue-of-bioresearch-open-access-launched-by-mary-ann-liebert-inc-publishers.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[3],"tags":[],"class_list":["post-44967","post","type-post","status-publish","format-standard","hentry","category-genetic-engineering"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/44967"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=44967"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/44967\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=44967"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=44967"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=44967"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}